2. Introduction
Hepatic encephalopathy describes a spectrum of potentially reversible neuropsychiatric
abnormalities seen in patients with liver dysfunction and/or portosystemic shunting
The International Society for Hepatic Encephalopathy and Nitrogen Metabolism consensus
defines the onset of disorientation or asterixis as the onset of overt hepatic encephalopathy
3. CATEGORIZATION AND GRADING
Hepatic encephalopathy is categorized based on four factors:
1. Underlying disease
2. Severity of manifestations
3. Time course
4. Precipitating factors
Based on West haven’s Criteria
5. Lab abnormality
Elevated arterial and venous ammonia concentrations
Other potential markers - serum levels of 3-nitrotyrosine may be elevated in patients with
minimal hepatic encephalopathy.
7. Management
Acute therapy - The initial management of acute hepatic encephalopathy in patients with chronic
liver disease involves two steps:
●Identification and correction of precipitating causes
●Measures to lower the blood ammonia concentration – Lactulose, gut sterilization
8. Chronic therapy – with lactulose or lacitol aiming at 2 -3 soft stools per day
Nutritional therapy - In a trial that compared a daily diet of 30 to 35 kcal/kg and 1.0 to 1.5 g
vegetable protein/kg with no dietary intervention in 120 cirrhotic patients with MHE, the rate of
reversal of MHE was greater in those receiving nutritional therapy